Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
Cure Today
22h
Keytruda Improves Disease-Free Survival in Some With Urothelial Carcinoma
Among patients with high-risk muscle-invasive urothelial carcinoma, postsurgical Keytruda extended the time some lived ...
Zacks.com on MSN
22h
Pharma Stock Roundup: FDA Approvals for LLY, MRK, AZN & JNJ Drugs
This week, the FDA approved Eli Lilly’s LLY eczema drug, Ebglyss (lebrikizumab), and the expanded use of Novartis’ NVS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Secret Service admits failure
Released after guilty plea
Rallies in North Carolina
Sesame Place suit verdict
Lebanon: 31 dead in strike
Jurors begin deliberations
TN abortion law blocked
Russia threatens retaliation
Drug price challenge revived
$230 million crypto theft
Boeing defense chief exits
Pandas leaving for China
Feds subpoena Schaeffer
In-person voting begins
WI high court to decide
Bill to boost security OK'd
SC 1st execution in 13 years
Hand count approved in GA
Baby powder recalled
FDA approves flu vaccine
Top Hezbollah leader killed?
Sues pharmacy middlemen
144K+ Mavericks recalled
House repeals emission rules
Disney to stop using Slack
$3B for battery projects
Stein's ballot bid rejected
MS sheriff's office probe
Recalling 449K+ vehicles
1st rabies outbreak in seals
Hiker injured in bear attack
Related topics
Pembrolizumab
Merck
Summit
Lung cancer
Mesothelioma
Feedback